Abstract
Surgical resection is currently considered to be the definitive treatment for hepatocellular carcinoma (HCC) and the only one that offers the prospect of cure or at least long‐term survival. However, most patients have unresectable disease at presentation because of poor liver function (about 75% will have underlying chronic liver disease), bilobar disease, invasion of the major vessels or overt extrahepatic metastases. The overall resectability rate for HCC is thus only 10–25% and even among those who undergo surgical resection with curative intent, there is a recurrence rate of up to 80% at 5 years 1 x [1] Nagao, T., Panis, Y., Farges, O., Benhamou, J.P., and Fekete, F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991; 241: 114–117 Google Scholar See all References , 2 x [2] Nagao, T., Inoue, S., Yoshimi, F., Sodeyama, M., Omori, Y., and Mizuta, T. Post operative recurrence of hepatocellular carcinoma. Ann Surg. 1990; 211: 28–33 Crossref | PubMed | Scopus (201) | Google Scholar See all References , 3 x [3] Nagasue, N., Uchida, M., Makino, Y., Takemoto, Y., Yamanoi, A., and Hayashi, T. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993; 105: 488–494 Abstract | Full Text PDF | PubMed | Scopus (16) | Google Scholar See all References . More recently there have been suggestions that other therapeutic modalities such as percutaneous ethanol injection (PEI) and radiofrequency ablation (RFA) are also potentially “curative”. It should be noted that the term “curative” in this sense is usually meant to imply “resulting in complete local control of the original lesion”. Cure in the strict and true sense of the word is seldom achieved.

This publication has 53 references indexed in Scilit: